发明申请
US20070037780A1 Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
审中-公开
提供仅孕激素避孕的制剂和方法，同时最小化与之相关的不良副作用
- 专利标题： Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
- 专利标题（中）： 提供仅孕激素避孕的制剂和方法，同时最小化与之相关的不良副作用
-
申请号： US11205297申请日： 2005-08-15
-
公开(公告)号： US20070037780A1公开(公告)日： 2007-02-15
- 发明人: Charles Ebert , Gary Hoel , Angela Anigbogu , Samir Roy
- 申请人： Charles Ebert , Gary Hoel , Angela Anigbogu , Samir Roy
- 主分类号： A61K31/57
- IPC分类号： A61K31/57
摘要：
Formulations and methods for providing progestin-only contraception to a woman while minimizing various side effects, such as breakthrough bleeding, that are normally associated with progestin-only contraception are disclosed and described. In one aspect, the method can include transdermally administering a formulation having a contraceptively effective amount of a single progestin as the sole active hormonal agent to the woman as part of a contraceptive regimen.